Andrositol® TEST as Diagnostic Assay to Predict the Fertilization Potential in IVF

Completed · Not applicable

Conditions studied: Male Infertility

In brief

Andrositol® test allows to obtain additional information besides the WHO parameters and to evaluate the semen energetic status. The diagnosis is performed by analyzing the semen at two different time points: before the treatment and 30' after the addiction of myo-inositol directly to the semen. The purpose of this study is to evaluate if the responsiveness to the Andrositol® test of a sperm sample can be predictive of its fertilization rate in an ICSI (Intracytoplasmic Sperm Injection) cycle (primary outcome). Secondary outcomes as embryo development, embryo euploidy status and embryo implantation rate will be evaluated.

Key facts

Study ID

NCT03677011

Run by

Lo.Li.Pharma s.r.l

People needed

249

Starts

2018-07-01

Expected to finish

2021-10-31

Last updated by the study team

2022-04-06

Who can join

Age: 18 and older, up to 50. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• male partners of couples undergoing an egg donor cycles

You may not qualify if…

• sperm volume lower than 1 ml
• sperm count lower than 5 X 106 /ml
• total sperm motility lower than 10%

Where it is running

• HRC Pasadena — Pasadena, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.